Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus (2015)

  • Authors:
  • USP affiliated authors: HUEB, WHADY ARMINDO - FM ; RAMIRES, JOSE ANTONIO FRANCHINI - FM ; KALIL FILHO, ROBERTO - FM ; MARANHAO, RAUL CAVALCANTE - FCF
  • USP Schools: FM; FM; FM; FCF
  • DOI: 10.1186/s12933-015-0270-8
  • Subjects: DOENÇAS CARDIOVASCULARES; LIPÍDEOS (METABOLISMO); COLESTEROL (INCIDÊNCIA); DIABETES MELLITUS (COMPLICAÇÕES); CORONARIOPATIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/s12933-015-0270-8 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: hybrid
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1186/s12933-015-0270-8 (Fonte: Unpaywall API)

    Título do periódico: Cardiovascular Diabetology

    ISSN: 1475-2840

    • Melhor URL em Acesso Aberto:


    • Outras alternativas de URLs em Acesso Aberto:


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Link para o PDF
        • Evidência: oa repository (via OAI-PMH title and first author match)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: Cardiovascular Diabetology

    ISSN: 1475-2840

    Citescore - 2017: 5.21

    SJR - 2017: 2.157

    SNIP - 2017: 1.368


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2716420-10BCSEP^299^2015
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SPRANDEL, Marilia C. O.; HUEB, Whady A.; SEGRE, Alexandre; et al. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. Cardiovascular Diabetology, London, v. 14, n. 107, p. 9 (on-line), 2015. Disponível em: < http://www.cardiab.com/content/pdf/s12933-015-0270-8.pdf > DOI: 10.1186/s12933-015-0270-8.
    • APA

      Sprandel, M. C. O., Hueb, W. A., Segre, A., Scudeler, T. L., Garzillo, C. L., Lima, E. G., et al. (2015). Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus. Cardiovascular Diabetology, 14( 107), 9 (on-line). doi:10.1186/s12933-015-0270-8
    • NLM

      Sprandel MCO, Hueb WA, Segre A, Scudeler TL, Garzillo CL, Lima EG, Segre CAW, Girardi P, Takiuti M, Silva MF, Ramires JAF, Kalil Filho R, Maranhão RC. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus [Internet]. Cardiovascular Diabetology. 2015 ; 14( 107): 9 (on-line).Available from: http://www.cardiab.com/content/pdf/s12933-015-0270-8.pdf
    • Vancouver

      Sprandel MCO, Hueb WA, Segre A, Scudeler TL, Garzillo CL, Lima EG, Segre CAW, Girardi P, Takiuti M, Silva MF, Ramires JAF, Kalil Filho R, Maranhão RC. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus [Internet]. Cardiovascular Diabetology. 2015 ; 14( 107): 9 (on-line).Available from: http://www.cardiab.com/content/pdf/s12933-015-0270-8.pdf

    Referências citadas na obra
    Pasterkamp G (2013) Methods of accelerated atherosclerosis in diabetic patients. Heart 99:743–749
    Leança CC, Nunes VS, Panzoldo NB, Zago VS, Parra ES, Cazita PM et al (2013) Metabolism of plasma cholesterol and lipoprotein parameters are related to a higher degree of insulin sensitivity in high HDL-C healthy normal weight subjects. Cardiovasc Diabetol 12:173
    Mooradian AD (2009) Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 5:150–159
    Fruchart JC, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G et al (2014) Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol 13:26
    Yassine HN, Belopolskaya A, Schall C, Stump CS, Lau SS, Reaven PD (2014) Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes. Metabolism 63:727–734
    Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707–714
    Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8–15
    Acharjee S, Boden WE, Hartigan PM, Teo KK, Maron DJ, Sedlis SP et al (2013) Low Levels of high density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post hoc analysis from the COURAGE Trial. J Am Coll Cardiol 62:1826–1833
    Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a newtherapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342–374
    Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J et al (2012) Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125:1905–1919
    Tall A (1995) Plasma lipid transfer proteins. Ann Rev Biochem 64:235–257
    Siebel AL, Natoli AK, Yap FY, Carey AL, Reddy-Luthmoodoo M, Sviridov D et al (2013) Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion. Circ Res 113:167–175
    Abbasi A, Dallinga-Thie GM, Dullaart RP (2015) Phospholipid transfer protein activity and incident type 2 diabetes mellitus. Clin Chim Acta 439:38–41
    Barter PJ, Rye KA (2012) Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. J Lipid Res 53:1755–1766
    Low H, Hoang A, Forbes J, Thomas M, Lyons JG, Nestel P et al (2012) Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models. Diabetologia 55:2513–2521
    Lo Prete AC, Dina CH, Azevedo CH, Puk CG, Lopes NH, Hueb WA et al (2009) In vitro simultaneous transfer of lipids to HDL in coronary artery disease and in statin treatment. Lipids 44:917–924
    Maranhao RC, Freitas FR (2014) HDL metabolism and atheroprotection: predictive value of lipid transfers. Adv Clin Chem 65:1–41
    Maranhao RC, Freitas FR, Strunz CM, Santos RD, Mansur AJ, Mansur AP et al (2012) Lipid transfers to HDL are predictors of precocious clinical coronary heart disease. Clin Chim Acta 413:502–505
    Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene AD et al (1995) The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 26:1600–1605
    Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
    Lima E, Maranhão RC (2004) Rapid, simple laser-light scattering method for HDL particle size in whole plasma. Clin Chem 50:1086–1091
    Bragdon JH, Eder HA, Gould RG, Havel RJ (1956) Lipid nomenclature: recommendations regarding the reporting of serum lipids and lipoproteins made by the Committee on Lipid and Lipoprotein Nomenclature of the American Society for the Study of Arteriosclerosis. Circ Res 4:129
    Marotta T, Russo BF, Ferrara LA (2010) Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients. Obesity 18:1608–1613
    Hermans MP, Ahn SA, Rousseau MF (2014) Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids. Cardiovasc Diabetol 13:56
    Seviour PW, Teal TK, Richmond W, Elkeles RS (1988) Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med 5:166–171
    Kahri J, Syvanne M, Taskinen MR (1994) Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 43:1498–1502
    Frohlich J, Dobiasova M (2003) Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 49:1873–1880
    Ng DS (2012) The role of lecithin: cholesterol acyltransferase in the modulation of cardiometabolic risks—a clinical update and emerging insights from animal models. Biochim Biophys Acta 1821:654–659
    Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T (2012) Very low levels of HDL cholesterol and atherosclerosis, a variable relationship—a review of LCAT deficiency. Vasc Health Risk Manag 8:357–361
    Rousset X, Shamburek R, Vaisman B, Amar M, Remaley AT (2011) Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor? Curr Atheroscler Rep 13:249–256
    Couto RD, Dallan LA, Lisboa LA, Mesquita CH, Vinagre CG, Maranhao RC (2007) Deposition of free cholesterol in the blood vessels of patients with coronary artery disease: a possible novel mechanism for atherogenesis. Lipids 42:411–418
    Santos RD, Hueb W, Oliveira AA, Ramires JA, Maranhao RC (2003) Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease. J Lipid Res 44:464–469
    Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K et al (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. New Eng J Med 364:127–135
    Triolo M, Kwakernaak AJ, Perton FG, de Vries R, Dallinga-Thie GM, Dullaart RP et al (2013) Low normal thyroid function enhances plasma cholesteryl ester transfer in type 2 diabetes mellitus. Atherosclerosis 228:466–471
    Dullaart RP, de Vries R, Dallinga-Thie GM, van Tol A, Sluiter WJ (2007) Plasma cholesteryl ester transfer protein mass and phospholipid transfer protein activity are associated with leptin in type 2 diabetes mellitus. Biochim Biophys Acta 1771:113–118
    Inukai Y, Ito K, Hara K, Yamazaki A, Takebayashi K, Aso Y et al (2007) Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus. Med Princ Pract. 16:367–372
    Morton RE (1988) Free cholesterol is a potent regulator of lipid transfer protein function. J Biol Chem 263:12235–12241